iohexol has been researched along with Cirrhosis, Liver in 25 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To define the percentage of small (≤2 cm) hepatocellular carcinoma (HCC) nodules showing the diagnostic enhancement pattern at CEUS, computed tomography (CT), and gadobenate dimeglumine (Gd-BOPTA)-enhanced magnetic resonance (MR) imaging." | 3.79 | Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria. ( Angileri, R; Cabibbo, B; Cova, MA; De Paoli, L; Pizzolato, R; Quaia, E, 2013) |
| "CT portography was performed in 118 cirrhosis patients with body mass index (BMI) less than 25 kg/m under 2 protocols: Protocol A, tube voltage of 90 kVp/395 mAs and contrast agent dosage of 1." | 2.87 | Computed tomography portography of patients with cirrhosis with normal body mass index: Comparison between low-tube-voltage CT with low contrast agent dose and conventional CT. ( Fan, J; He, J; Li, W; Liu, S; Sheng, H; Shi, H; Sun, H, 2018) |
| "Purpose To stage liver fibrosis by using 5-minute delayed DECT and compare findings with those of transient elastography (TE), shear-wave elastography (SWE), and histologic examination." | 1.62 | Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings. ( Das, P; Kalaivani, M; Madhusudhan, KS; Marri, UK; Srivastava, DN, 2021) |
| "Owing to nonspecific clinical symptoms, Wilson disease (WD) diagnosis is often missed or delayed; hence, many patients reach end-stage liver disease." | 1.56 | Assessment of the Hallmarks of Wilson Disease in CT Scan Imaging. ( Haseli, S; Iranpour, P; Jafari, SH; Kaffashan, S; Saeedi-Moghadam, M; Zeinali-Rafsanjani, B, 2020) |
| "Endoscopy is recommended to screen for esophageal varices in patients with cirrhosis." | 1.40 | Esophageal varices on computed tomography and subsequent variceal hemorrhage. ( Ali, M; Aslam, R; Inadomi, JM; Monto, A; Somsouk, M; To'o, K; Vittinghoff, E; Yee, J; Yeh, BM, 2014) |
| "In patients with liver cirrhosis a urine protein:creatinine ratio >30 predicts AKI." | 1.39 | Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers. ( Auzinger, G; Bernal, W; Bruce, M; Dew, T; Heneghan, MA; McPhail, MJ; Moore, K; Musto, R; O'Grady, J; Ostermann, M; Sherwood, R; Slack, AJ; Wendon, JA, 2013) |
| "Most patients with HCC have coexisting liver cirrhosis (LC) at the time of diagnosis." | 1.37 | Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. ( Bae, EJ; Chang, SH; Cho, HS; Kang, Y; Kim, HJ; Park, DJ; Seo, JW, 2011) |
| "In the rabbits with liver fibrosis, the mean transit time of the high-molecular-mass agent was shorter than that of the low-molecular-mass agent (10." | 1.31 | Dynamic computed tomography with low- and high-molecular-mass contrast agents to assess microvascular permeability modifications in a model of liver fibrosis. ( Annet, L; Corot, C; Dechambre, S; Horsmans, Y; Materne, R; Sempoux, C; Smith, AM; Van Beers, BE, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 18 (72.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jafari, SH | 1 |
| Haseli, S | 1 |
| Kaffashan, S | 1 |
| Saeedi-Moghadam, M | 1 |
| Iranpour, P | 1 |
| Zeinali-Rafsanjani, B | 1 |
| Gerova, VA | 1 |
| Svinarov, DA | 1 |
| Nakov, RV | 1 |
| Stoynov, SG | 1 |
| Tankova, LT | 1 |
| Nakov, VN | 1 |
| Marri, UK | 1 |
| Das, P | 1 |
| Kalaivani, M | 1 |
| Srivastava, DN | 1 |
| Madhusudhan, KS | 1 |
| Jia, GS | 1 |
| Feng, GL | 1 |
| Li, JP | 1 |
| Xu, HL | 1 |
| Wang, H | 1 |
| Cheng, YP | 1 |
| Yan, LL | 1 |
| Jiang, HJ | 1 |
| Liu, S | 1 |
| Sheng, H | 1 |
| Shi, H | 1 |
| Li, W | 1 |
| Fan, J | 1 |
| He, J | 1 |
| Sun, H | 1 |
| Slack, AJ | 1 |
| McPhail, MJ | 1 |
| Ostermann, M | 1 |
| Bruce, M | 1 |
| Sherwood, R | 1 |
| Musto, R | 1 |
| Dew, T | 1 |
| Auzinger, G | 1 |
| Bernal, W | 1 |
| O'Grady, J | 1 |
| Heneghan, MA | 1 |
| Moore, K | 2 |
| Wendon, JA | 1 |
| Slack, A | 1 |
| Tredger, M | 1 |
| Brown, N | 1 |
| Corcoran, B | 1 |
| Zhao, LQ | 1 |
| He, W | 1 |
| Yan, B | 1 |
| Wang, HY | 1 |
| Wang, J | 1 |
| Sauter, AW | 1 |
| Spira, D | 1 |
| Schulze, M | 1 |
| Horger, MS | 1 |
| Quaia, E | 1 |
| De Paoli, L | 1 |
| Angileri, R | 1 |
| Pizzolato, R | 1 |
| Cabibbo, B | 1 |
| Cova, MA | 1 |
| Francoz, C | 2 |
| Nadim, MK | 1 |
| Baron, A | 1 |
| Prié, D | 2 |
| Antoine, C | 1 |
| Belghiti, J | 2 |
| Valla, D | 2 |
| Moreau, R | 2 |
| Durand, F | 2 |
| Zissen, MH | 1 |
| Wang, ZJ | 1 |
| Yee, J | 2 |
| Aslam, R | 2 |
| Monto, A | 2 |
| Yeh, BM | 2 |
| Somsouk, M | 1 |
| To'o, K | 1 |
| Ali, M | 1 |
| Vittinghoff, E | 1 |
| Inadomi, JM | 1 |
| Lee, S | 1 |
| Choi, D | 1 |
| Jeong, WK | 1 |
| Kim, YK | 1 |
| Lim, JH | 1 |
| Choi, MS | 1 |
| Park, CK | 1 |
| Bandula, S | 1 |
| Punwani, S | 1 |
| Rosenberg, WM | 1 |
| Jalan, R | 1 |
| Hall, AR | 1 |
| Dhillon, A | 1 |
| Moon, JC | 1 |
| Taylor, SA | 1 |
| Lewin, M | 1 |
| Gelu-Simeon, M | 1 |
| Ostos, M | 1 |
| Boufassa, F | 1 |
| Sobesky, R | 1 |
| Teicher, E | 1 |
| Meyer, L | 1 |
| Fontaine, H | 1 |
| Salmon-Céron, D | 1 |
| Samuel, D | 1 |
| Seror, O | 1 |
| Trinchet, JC | 1 |
| Duclos-Vallée, JC | 1 |
| Li, R | 1 |
| Cai, P | 1 |
| Ma, KS | 1 |
| Ding, SY | 1 |
| Guo, DY | 1 |
| Yan, XC | 1 |
| Nakai, M | 1 |
| Sato, M | 1 |
| Ikoma, A | 1 |
| Nakata, K | 1 |
| Sahara, S | 1 |
| Takasaka, I | 1 |
| Minamiguchi, H | 1 |
| Kawai, N | 1 |
| Sonomura, T | 1 |
| Kishi, K | 1 |
| Ronot, M | 1 |
| Asselah, T | 1 |
| Paradis, V | 1 |
| Michoux, N | 1 |
| Dorvillius, M | 1 |
| Baron, G | 1 |
| Marcellin, P | 1 |
| Van Beers, BE | 3 |
| Vilgrain, V | 1 |
| Abdelrazek, W | 1 |
| Mandot, A | 1 |
| Cho, HS | 1 |
| Seo, JW | 1 |
| Kang, Y | 1 |
| Bae, EJ | 1 |
| Kim, HJ | 1 |
| Chang, SH | 1 |
| Park, DJ | 1 |
| Materne, R | 2 |
| Annet, L | 1 |
| Dechambre, S | 1 |
| Sempoux, C | 1 |
| Smith, AM | 2 |
| Corot, C | 1 |
| Horsmans, Y | 2 |
| Hayashi, M | 1 |
| Matsui, O | 1 |
| Ueda, K | 1 |
| Kawamori, Y | 1 |
| Gabata, T | 1 |
| Kadoya, M | 1 |
| Lee, HM | 1 |
| Lu, DS | 1 |
| Krasny, RM | 1 |
| Busuttil, R | 1 |
| Kadell, B | 1 |
| Lucas, J | 1 |
| Leconte, I | 1 |
| Jamart, J | 1 |
1 trial available for iohexol and Cirrhosis, Liver
| Article | Year |
|---|---|
Computed tomography portography of patients with cirrhosis with normal body mass index: Comparison between low-tube-voltage CT with low contrast agent dose and conventional CT.
Topics: Adult; Aged; Body Mass Index; Contrast Media; Dose-Response Relationship, Drug; Female; Humans; Iohe | 2018 |
24 other studies available for iohexol and Cirrhosis, Liver
| Article | Year |
|---|---|
Assessment of the Hallmarks of Wilson Disease in CT Scan Imaging.
Topics: Adolescent; Adult; Child; Contrast Media; Female; Hepatolenticular Degeneration; Humans; Iohexol; Li | 2020 |
Intestinal barrier dysfunction in liver cirrhosis assessed by iohexol test.
Topics: Adult; Aged; Female; Healthy Volunteers; Humans; Intestinal Diseases; Iohexol; Liver Cirrhosis; Male | 2020 |
Noninvasive Staging of Liver Fibrosis Using 5-Minute Delayed Dual-Energy CT: Comparison with US Elastography and Correlation with Histologic Findings.
Topics: Adult; Biopsy; Contrast Media; Elasticity Imaging Techniques; Female; Humans; Iohexol; Liver Cirrhos | 2021 |
Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Hepatocellular; Case-Control Studies; C | 2017 |
Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Adult; Aged; Biomarkers; Cohort Studies; Contrast Media; | 2013 |
Application of an isocratic methanol-based HPLC method for the determination of iohexol concentrations and glomerular filtration rate in patients with cirrhosis.
Topics: Adult; Aged; Ascitic Fluid; Chromatography, High Pressure Liquid; Chromium Radioisotopes; Creatinine | 2014 |
The evaluation of haemodynamics in cirrhotic patients with spectral CT.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Hemodynamics; Humans; Hypertension, Portal; | 2013 |
Explanations for the heterogeneity of splenic enhancement derived from blood flow kinetic measurements using dynamic contrast-enhanced CT (DCE-CT).
Topics: Adult; Aged; Aged, 80 and over; Blood Flow Velocity; Blood Volume; Contrast Media; Female; Humans; I | 2014 |
Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Im | 2013 |
Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: validation of current recommendations.
Topics: Adult; Aged; Comorbidity; Disease Management; Female; Glomerular Filtration Rate; Humans; Iohexol; K | 2014 |
Contrast-enhanced CT quantification of the hepatic fractional extracellular space: correlation with diffuse liver disease severity.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Contrast Media; Extracellular Space; Female; H | 2013 |
Esophageal varices on computed tomography and subsequent variceal hemorrhage.
Topics: Case-Control Studies; Contrast Media; Diatrizoate; Diatrizoate Meglumine; Esophageal and Gastric Var | 2014 |
Frequency, CT findings, and fate of multiple infarcted regenerative nodules in liver cirrhosis after variceal bleeding or septic shock.
Topics: Aged; Comorbidity; Contrast Media; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastro | 2015 |
Equilibrium contrast-enhanced CT imaging to evaluate hepatic fibrosis: initial validation by comparison with histopathologic sampling.
Topics: Adult; Aged; Biopsy; Contrast Media; Female; Humans; Iohexol; Liver Cirrhosis; Male; Middle Aged; Pr | 2015 |
Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Coinfection; Contrast Media; Diagnostic Imaging; Female; Fra | 2015 |
Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagn | 2016 |
Triple-phase computed tomography during arterial portography with bolus tracking for hepatic tumors.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Digestive System Neoplasms; Female; Hepatitis C; Hu | 2010 |
Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Contrast Media; Female; Hepatitis C, Chronic; Humans; Iohexo | 2010 |
Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score.
Topics: Adult; Aged; Biomarkers; Contrast Media; Creatinine; Female; France; Glomerular Filtration Rate; Hea | 2010 |
Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Topics: Acute Kidney Injury; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media | 2011 |
Dynamic computed tomography with low- and high-molecular-mass contrast agents to assess microvascular permeability modifications in a model of liver fibrosis.
Topics: Animals; Capillary Permeability; Contrast Media; Iohexol; Liver; Liver Cirrhosis; Male; Molecular We | 2002 |
Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Disease Progression; Female; Hepatic Artery; | 2002 |
Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; Liver; Liver Cirrho | 1997 |
Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity.
Topics: Case-Control Studies; Chronic Disease; Contrast Media; Female; Humans; Iohexol; Liver Circulation; L | 2001 |